Identification of consistent novel submegabase deletions in low-grade oligodendrogliomas using array-based...

Area of Science:

• Neuro-oncology
• Genomics
• Cancer genetics

Background:

• Low-grade gliomas are a heterogeneous group of brain tumors.
• Specific chromosomal alterations, such as 1p and 19q loss, are common in certain low-grade gliomas.
• Array comparative genomic hybridization (aCGH) allows for high-resolution analysis of genomic copy number variations.

Purpose of the Study:

• To identify submegabase hemizygous deletions in low-grade gliomas.
• To define novel genomic regions associated with tumor development.
• To discover potential diagnostic markers for low-grade gliomas.

Main Methods:

• Analysis of 18 low-grade gliomas using array comparative genomic hybridization (aCGH) with <500 kb resolution.
• Application of custom statistical methods to identify hemizygous deletions correlated with 19q loss.
• Fluorescence in situ hybridization (FISH) to confirm identified deletions.

Main Results:

• Identified a ~550-kb region in 11q13 and a ~300-kb region in 13q12 with hemizygous deletion in most analyzed tumors, irrespective of 1p/19q status.
• Confirmed hemizygous loss in these regions using FISH.
• Characterized the spectrum of genomic gains and losses in low-grade oligodendrogliomas.

Conclusions:

• The identified 11q13 and 13q12 regions represent potential diagnostic markers for a subgroup of low-grade gliomas.
• These deletions encompass candidate genes that may play a role in tumorigenesis.
• aCGH is a valuable tool for defining the genomic landscape of low-grade gliomas.